Skip to main content

Table 4 Glycemic markers at baseline and follow-up

From: Low and exacerbated levels of 1,5-anhydroglucitol are associated with cardiovascular events in patients after first-time elective percutaneous coronary intervention

 

Baseline

Follow-up

Event (+) (n = 40)

Event (−) (n = 200)

P value

Event (+) (n = 40)

Event (−) (n = 200)

P value

FBS (mg/dl)

100 ± 15

97 ± 19

0.41

100 ± 19

97 ± 18

0.31

HbA1c (%)

5.9 ± 0.5

5.9 ± 0.5

0.77

6.0 ± 0.7

5.9 ± 0.5

0.84

1,5-AG (μg/ml)

16.5 ± 6.7

17.7 ± 7.1

0.29

14.5 ± 6.6

17.3 ± 7.0

0.02

  1. Data are presented as mean ± SD
  2. FBS fasting blood glucose, HbA1c hemoglobin A1C, 1,5-AG 1,5-anhydroglucitol
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840